Mechanics insights of curcumin in myocardial ischemia: Where are we standing?

Area of Science:

• Biochemistry
• Pharmacology
• Cardiovascular Research

Background:

• Cardiovascular disorders contribute significantly to global mortality.
• Myocardial ischemia (MI) is a critical condition leading to severe complications like atherosclerosis and hypertension.
• Current therapeutic strategies for MI offer limited efficacy, necessitating novel treatment approaches.

Purpose of the Study:

• To review the cardioprotective effects of curcumin (CRC) against myocardial ischemia (MI).
• To explore the mechanisms underlying CRC's protective actions, focusing on inflammation and oxidative stress.
• To establish CRC as a potential therapeutic agent for MI and stimulate further clinical research.

Main Methods:

• Literature review of existing studies on curcumin and cardiovascular diseases.
• Analysis of research investigating the impact of curcumin on inflammation and oxidative stress pathways.
• Synthesis of evidence regarding curcumin's efficacy in preclinical models of myocardial ischemia.

Main Results:

• Curcumin (CRC) demonstrates significant cardioprotective properties against myocardial ischemia (MI).
• CRC exerts its effects by modulating key mechanisms including inflammation and oxidative stress.
• Evidence suggests CRC and its analogs hold promise for managing MI-related complications.

Conclusions:

• Curcumin (CRC) presents a promising natural compound for therapeutic intervention in myocardial ischemia (MI).
• Further clinical investigations are warranted to explore the full therapeutic potential of CRC in cardiovascular diseases.
• CRC offers a potential novel therapeutic strategy for addressing unmet needs in MI treatment.